BRIEF-EU medicines agency backs Bristol Myers Squibb's melanoma drug

* Recommends approval of melanoma drug nivolumab from Bristol-Myers Squibb Co
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.